Catalent and OSO expand ‘controlled substances’ businesses
Catalent and OSO BioPharmaceuticals Manufacturing have both announced expansions to their controlled substances businesses in the last week.
Archives for July 3, 2011
Tox demand & capacity use up but pricing unresponsive
Demand for toxicology services is growing steadily but pricing remains depressed, despite an upturn in capacity use, according to an analyst.
Chimerix drops BARDA protest after contract modification
Siga Technologies can resume work on scale-up of a smallpox antiviral after Chimerix dropped its protest following a contract modification.
USP publishes free drug quality standards collection online
The USP has published a free, online collection of standards to support drug quality, particularly where regulatory resources are limited.
Parexel talks global trial regulations at DIA 2011
US CRO Parexel says the pharmaceutical industry’s desire to access international markets is the key challenge facing regulatory experts in the contract research sector.